SCHEMBL30833399

SCHEMBL30833399

Cn1nc(C(F)F)cc1S(=O)(=O)C(C)(F)C1CCCCN1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
WNT3 P56703 2/20 0.35
SFRP1 Q8N474 2/20 0.35
NR1H2 P55055 3/20 0.33
NR1H3 Q13133 2/20 0.33
LMNA P02545 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
STS P08842 1/20 0.32
TRPV1 Q8NER1 1/20 0.32
NPC1 O15118 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833506 0.87 SFRP1 (0.39) MEN1KMT2AWNT3SFRP1NR1H2
SCHEMBL30833482 0.82 MEN1 (0.40) MEN1KMT2AWNT3SFRP1NR1H2
SCHEMBL17948865 0.82 STS (0.44) STS
SCHEMBL30833505 0.81 MEN1 (0.38) MEN1KMT2ANR1H2NR1H3TRPV1
SCHEMBL30833493 0.80 MEN1 (0.38) MEN1KMT2AWNT3SFRP1NR1H2
SCHEMBL30833508 0.80 WNT3 (0.36) MEN1KMT2AWNT3SFRP1NR1H2
SCHEMBL30833457 0.79 MEN1 (0.35) MEN1KMT2AWNT3SFRP1STS
SCHEMBL30833456 0.79 RORC (0.35) WNT3SFRP1LMNATRPV1ALDH1A1
SCHEMBL30833490 0.78 WNT3 (0.35) MEN1KMT2AWNT3SFRP1NR1H2
SCHEMBL18025947 0.76 HTR7 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118164961-A 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-06-11 CN disclosed
CN-111393414-B 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-05-07 CN disclosed